EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte Studie

Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study

Virendra Singh, Arka De, Rishav Aggrawal, Akash Singh, Swati Charak, Naveen Bhagat

Digestive Diseases and Sciences · 2025-02 · 70 (2) · 835-842

DOI: 10.1007/s10620-024-08667-4 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 09.10.2024. Verfasst von Virendra Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. virendrasingh100@hotmail.com. Hauptthemen laut MEDLINE: Ascites, Benzhydryl Compounds, Glucosides, Liver Cirrhosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AscitesBenzhydryl CompoundsGlucosidesLiver CirrhosisSodium-Glucose Transporter 2 InhibitorsAdultAgedFemaleHumansMaleMiddle AgedAcute Kidney InjuryDouble-Blind MethodPilot ProjectsRecurrenceTreatment Outcome

Stichwörter der Autor:innen

CirrhosisDecompensated cirrhosisGliflozinNatriuresisSGLT-2 inhibitor

Substanzen

Benzhydryl CompoundsdapagliflozinGlucosidesSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. virendrasingh100@hotmail.com.
  • Punjab Institute of Liver and Biliary Sciences, Mohali, India. virendrasingh100@hotmail.com.
  • Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Albert Einstein Healthcare Network, Philadelphia, USA.

Zitieren

APA

Singh, V., De, A., Aggrawal, R., Singh, A., Charak, S., & Bhagat, N. (2025). Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study. Digestive Diseases and Sciences, 70(2), 835-842. https://doi.org/10.1007/s10620-024-08667-4

Vancouver

Singh V, De A, Aggrawal R, Singh A, Charak S, Bhagat N. Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study. Digestive Diseases and Sciences. 2025;70(2):835-842. doi:10.1007/s10620-024-08667-4

BibTeX
@article{Singh2025,
  author = {Singh, Virendra and De, Arka and Aggrawal, Rishav and Singh, Akash and Charak, Swati and Bhagat, Naveen},
  title = {Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  volume = {70},
  number = {2},
  pages = {835--842},
  doi = {10.1007/s10620-024-08667-4}
}
Kostenlos starten →